Financial statements Noble Medicine Premium W Likwidacji
Balance sheet data of NOBLE MEDICINE PREMIUM W LIKWIDACJI
Year
|
2017
|
2019
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 248 432,97 | 995 556,44 | 979 790,42 | 490 546,33 | 383 525,18 |
A. Fixed assets | 34 509,78 | 93 578,26 | 504 113,60 | 70 465,49 | 66 136,91 |
B. Current assets | 213 923,19 | 901 978,18 | 475 676,82 | 420 080,84 | 317 388,27 |
C. Share capital contributions (basic funds) | 0,00 | - | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | - | 0,00 | 0,00 | 0,00 |
Total liabilities | 248 432,97 | 995 556,44 | 979 790,42 | 490 546,33 | 383 525,18 |
A. Equity | -226 470,85 | 791 407,75 | 747 289,81 | 289 863,03 | 251 968,17 |
B. Liabilities and provisions for liabilities | 474 903,82 | 204 148,69 | 232 500,61 | 200 683,30 | 131 557,01 |
I. Long-term liabilities | 250 940,92 | 23 698,10 | 0,00 | 20 295,00 | 20 295,00 |
II. Short-term liabilities | 223 962,90 | 180 450,59 | 218 597,39 | 180 388,30 | 111 262,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.